| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |